vimarsana.com

Latest Breaking News On - Restated listing statement - Page 6 : vimarsana.com

Braxia Scientific Announces Board Appointment

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) a medical research and telemedicine.

United statesState of floridaRogers mcintyreLeann taylorBraxia healthBraxia scientific corpExcellence incKetamd incCanadian rapid treatment centerBraxia scientificControlled drugsSubstances actRestated listing statementBraxia scientific corp

Braxia Scientific Announces Court Approval of Class Action Settlement in Canada

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) announced today that the Supreme Court of.

United statesUnited kingdomRogers mcintyreBraxia healthSupreme courtBraxia scientific corpExcellence incUnited states district courtHealth canadaCanadian rapid treatment centerBritish columbiaBraxia scientificCanadian settlementCentral districtControlled drugsSubstances act

Braxia Scientific to Present at H C Wainwright 24th Annual Global Investment Conference September 12-14, 2022

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine.

New yorkUnited statesRogers mcintyreRoger mcintyreBraxia healthBraxia scientific corpExcellence incHealth canadaCanadian rapid treatment centerGlobal annual investment conferenceControlled drugsSubstances actRestated listing statementBraxia scientific corp

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U S Increasing Treatment Access for Mental Health Patients

TORONTO, Aug. 29, 2022 /PRNewswire/ - Braxia Scientific Corp. , , a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression.

United statesState of floridaRoger mcintyreRogers mcintyreBraxia healthBraxia scientific corpAccess to mental health therapiesToronto the companyExcellence incCanadian securities exchange onBraxia health canadaHealth canadaBraxia instituteCanadian rapid treatment centerAccess programElectronic document analysis

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U S Increasing Treatment Access for Mental Health Patients

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine.

United statesState of floridaRoger mcintyreRogers mcintyreBraxia healthBraxia scientific corpAccess to mental health therapiesToronto the companyExcellence incCanadian securities exchange onBraxia health canadaHealth canadaBraxia instituteCanadian rapid treatment centerAccess programElectronic document analysis

vimarsana © 2020. All Rights Reserved.